Rebeca Vidal

2.0k citations

39 papers · 1.4k indexed · h-index 22

Impact in

Biological Psychiatry top 1%
- Tryptophan and brain disorders
Behavioral Neuroscience top 5%
- Stress Responses and Cortisol

Papers in

Biological Psychiatry 8
- Tryptophan and brain disorders 8
Developmental Neuroscience 8
- Neurogenesis and neuroplasticity mechanisms 8

Co-authors: Ángel Pazos Fuencisla Pilar-Cuéllar Álvaro Díaz Elena Castro Elsa M. Valdizán Raquel Linge Leticia Campa Albert Adell
Journals: Neuropharmacology (6 papers)Molecular Neurobiology (3 papers)Current Pharmaceutical Design (3 papers)British Journal of Pharmacology (3 papers)ACS Chemical Neuroscience (2 papers)
Partner nations: Spain United States France

In The Last Decade

Rebeca Vidal

39 papers receiving 1.4k citations

Peers

Countries citing papers authored by Rebeca Vidal

Since Specialization

Citations

This map shows the geographic impact of Rebeca Vidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebeca Vidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebeca Vidal more than expected).

Fields of papers citing papers by Rebeca Vidal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebeca Vidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebeca Vidal. The network helps show where Rebeca Vidal may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Rebeca Vidal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rebeca Vidal Line = papers co-authored together Rebeca Vidal links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Probing the oral-brain connection: oral microbiome patterns in a large community cohort with anxiety, depression, and trauma symptoms, and periodontal outcomes Translational Psychiatry ·Stefanie Malan‐Müller, Rebeca Vidal, Esther O’Shea, Eduardo Montero, Elena Figuero, Eric P. Zorrilla, Javier de Diego-Adeliño, Marta Cano, María Paz García‐Portilla, Ana González‐Pinto, Juan C. Leza	2024	22
2	Influx of kynurenine into the brain is involved in the reduction of ethanol consumption induced by Ro 61‐8048 after chronic intermittent ethanol in mice British Journal of Pharmacology ·Dika Gunawan Siswantoro, Agustín Ruiz, Chelsea Ward-Waller, Rebeca Vidal, C. Calle, María Dolores Gutiérrez‐López, Esther O’Shea, María Isabel Colado	2022	8
3	5-HT₄Receptors Are Not Involved in the Effects of Fluoxetine in the Corticosterone Model of Depression ACS Chemical Neuroscience ·A. Kułakowski, 裕子本田, Rebeca Vidal, Valérie Compan, Fuencisla Pilar-Cuéllar, Ángel Pazos, Álvaro Díaz, Elena Castro	2021	11
4	Addiction and the kynurenine pathway: A new dancing couple? Pharmacology & Therapeutics ·Chelsea Ward-Waller, Agustín Ruiz, Mark Smeets, Mo Danh, Dika Gunawan Siswantoro, Rebeca Vidal, María Dolores Gutiérrez‐López, Esther O’Shea, María Isabel Colado	2021	39
5	Decreased kynurenine pathway potentiate resilience to social defeat effect on cocaine reward Neuropharmacology ·Agustín Ruiz, Raúl Ballestín, Dika Gunawan Siswantoro, Rebeca Vidal, Carmen Ferrer‐Pérez, Marina D. Reguilón, Esther O’Shea, José Miñarro, María Isabel Colado, Marta Rodrı́guez-Arias	2021	14
6	Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Rebeca Vidal, Nuria García‐Marchena, Esther O’Shea, Abel Pallarés-Sanmartín, Alastair Howie, Pedro Araos, Antonia Serrano, Juan Suárez, Gabriel Rubio, Fernando Rodrı́guez de Fonseca, María Isabel Colado, Francisco Javier Pavón	2020	19
7	β-Catenin Role in the Vulnerability/Resilience to Stress-Related Disorders Is Associated to Changes in the Serotonergic System Molecular Neurobiology ·裕子本田, Rebeca Vidal, Albert Adell, Álvaro Díaz, Elena Castro, A. Kułakowski, Thobhanbhai Dholariya, محمد رضا حاجی اسماعیلی, FenFei, Makoto M. Taketo, Ángel Pazos, Fuencisla Pilar-Cuéllar	2019	8
8	Targeting β-Catenin in GLAST-Expressing Cells: Impact on Anxiety and Depression-Related Behavior and Hippocampal Proliferation Molecular Neurobiology ·Rebeca Vidal, 裕子本田, Álvaro Díaz, Elena Castro, محمد رضا حاجی اسماعیلی, Makoto M. Taketo, Ángel Pazos, Fuencisla Pilar-Cuéllar	2018	25
9	Enhanced Stress Response in 5-HT_1AR Overexpressing Mice: Altered HPA Function and Hippocampal Long-Term Potentiation ACS Chemical Neuroscience ·Fuencisla Pilar-Cuéllar, Rebeca Vidal, Álvaro Díaz, 裕子本田, Raquel Linge, Elena Castro, Ahmad Fadhullah Adzmi, Heidrun Fink, Bettina Bert, 吕志楠, Beatriz Romero, Benedicto Crespo‐Facorro, Ángel Pazos	2017	11
10	3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) produces edema due to BBB disruption induced by MMP-9 activation in rat hippocampus Neuropharmacology ·Mark Smeets, María Encarnación Fernández-Valle, Ana Rubio‐Araiz, Rebeca Vidal, María Dolores Gutiérrez‐López, Esther O’Shea, María Isabel Colado	2017	25
11	The Addiction-Related Protein ANKK1 is Differentially Expressed During the Cell Cycle in Neural Precursors Cerebral Cortex ·久仁子高橋, Arla Sai Kumar, Ana Montero‐Pedrazuela, Ahmed Kafafy, Rebeca Vidal, Inés García‐Consuegra, Elsa M. Valdizán, Ángel Pazos, Tomás Palomo, Miguel Ángel Jiménez‐Arriero, Ana Guadaño‐Ferraz, Janet Hoenicka	2016	12
12	Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors Neuropharmacology ·Raquel Linge, Laura Jiménez-Sánchez, Leticia Campa, Fuencisla Pilar-Cuéllar, Rebeca Vidal, Ángel Pazos, Albert Adell, Álvaro Díaz	2015	225
13	Signaling Pathways Involved in Antidepressant-Induced Cell Proliferation and Synaptic Plasticity Current Pharmaceutical Design ·Fuencisla Pilar-Cuéllar, Rebeca Vidal, Álvaro Díaz, Elena Castro, Severiano Dos-Anjos, O. Saglio, Beatriz Romero, Elsa M. Valdizán	2014	28
14	Reducing GABA _A α5 Receptor-Mediated Inhibition Rescues Functional and Neuromorphological Deficits in a Mouse Model of Down Syndrome Journal of Neuroscience ·Carmen Martínez‐Cué, Paula Martínez, Noemı́ Rueda, Rebeca Vidal, Susana García-Cerro, Verónica Vidal, Andrea Corrales, Juan A. Montero, Ángel Pazos, Jesús Flórez, Rodolfo Gasser, Andrew W. Thomas, Michael Honer, Frédéric Knoflach, José Luís Trejo, Joseph G. Wettstein, Maria‐Clemencia Hernandez	2013	122
15	Modulation of neuroplasticity pathways and antidepressant-like behavioural responses following the short-term (3 and 7 days) administration of the 5-HT4 receptor agonist RS67333 The International Journal of Neuropsychopharmacology ·Jesús Pascual-Brazo, Elena Castro, Álvaro Díaz, Elsa M. Valdizán, Fuencisla Pilar-Cuéllar, Rebeca Vidal, Ignacio N. Ibaldi, Ángel Pazos	2011	70
16	New Strategies in the Development of Antidepressants: Towards the Modulation of Neuroplasticity Pathways Current Pharmaceutical Design ·Rebeca Vidal, Fuencisla Pilar-Cuéllar, Severiano Dos-Anjos, Raquel Linge, Ignacio N. Ibaldi, O. Saglio, Antonio Rodríguez‐Gaztelumendi, Ricardo Mostany, Elena Castro, Álvaro Díaz, Elsa M. Valdizán, Ángel Pazos	2011	44
17	Long‐term treatment with fluoxetine induces desensitization of 5‐HT₄receptor‐dependent signalling and functionality in rat brain Journal of Neurochemistry ·Rebeca Vidal, Elsa M. Valdizán, Ricardo Mostany, Ángel Pazos, Elena Castro	2009	56
18	Long-Term Fluoxetine Treatment Modulates Cannabinoid Type 1 Receptor-Mediated Inhibition of Adenylyl Cyclase in the Rat Prefrontal Cortex through 5-Hydroxytryptamine1A Receptor-Dependent Mechanisms Molecular Pharmacology ·Susana Mato, Rebeca Vidal, Elena Castro, Álvaro Díaz, Ángel Pazos, Elsa M. Valdizán	2009	51
19	Hepatotoxicity of Antiretroviral Drugs Is Reduced after Successful Treatment of Chronic Hepatitis C in HIV‐Infected Patients The Journal of Infectious Diseases ·Pablo Labarga, Vincent Soriano, 太浅野, Javier Pinilla, Luz Martı́n-Carbonero, Carol Castellares, Rebeca Vidal, Ivana Maida, Pilar García‐Gascó, Pablo Barreiro	2007	112
20	Gene Transfer of NMDAR1 Subunit Sequences to the Rat CNS Using Herpes Simplex Virus Vectors Interfered with Habituation Cellular and Molecular Neurobiology ·Verónica T. Cheli, Martín F. Adrover, Carlos Blanco, Eugene V. Mischenko, Alireza Saadati, Rebeca Vidal, 誠男志関, Laura E. Alché, Gonzalo Sánchez, Xin Zhang, Alberto L. Epstein, Diana Jerusalinsky	2002	18

About Rebeca Vidal

Rebeca Vidal is a scholar working on Biological Psychiatry, Developmental Neuroscience, Behavioral Neuroscience, Cellular and Molecular Neuroscience and Pharmacology, having authored 39 papers that have together received 1.4k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (13 papers), Neurotransmitter Receptor Influence on Behavior (13 papers), Nerve injury and regeneration (8 papers), Tryptophan and brain disorders (8 papers), Neurogenesis and neuroplasticity mechanisms (8 papers), Stress Responses and Cortisol (5 papers), Down syndrome and intellectual disability research (4 papers) and Neuroendocrine regulation and behavior (4 papers). The work is most often cited by research in Biological Psychiatry (263 citations), Behavioral Neuroscience (162 citations), Cellular and Molecular Neuroscience (568 citations), Developmental Neuroscience (107 citations) and Pharmacology (400 citations). Rebeca Vidal has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Ángel Pazos, Fuencisla Pilar-Cuéllar, Álvaro Díaz, Elena Castro, Elsa M. Valdizán, Raquel Linge, Leticia Campa, Albert Adell, Laura Jiménez-Sánchez and Noemı́ Rueda. Their work appears in journals such as Neuropharmacology, Molecular Neurobiology, Current Pharmaceutical Design, British Journal of Pharmacology and ACS Chemical Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact